# ISENTRESS
> **NDA203045** · New Drug Application · Sponsor: MSD SUB MERCK · Approved 2011-12-21
## Drug
- **FDA Application Number:** NDA203045
- **Application type:** New Drug Application
- **Brand name:** ISENTRESS
- **Generic name:** RALTEGRAVIR
- **Active ingredients:** RALTEGRAVIR POTASSIUM
- **Dosage form:** TABLET, CHEWABLE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSD SUB MERCK
- **Manufacturer:** Merck Sharp & Dohme LLC
- **First approval:** 2011-12-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203045)
---
*MORVS · CC0 1.0*